HCC
1
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Merck & Co.TACE
PhilipsDouble Low-Dose protocol CT
Clinical Trials (2)
Total enrollment: 101 patients across 2 trials
Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy
Start: Mar 2019Est. completion: Jul 202333 patients
Phase 2Completed
"Double Low-Dose" DECT for HCC Imaging
Start: May 2017Est. completion: Sep 201968 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space